Treatment of Deep Vein Thrombosis (DVT)

Initial Management

The American College of Chest Physicians recommends direct oral anticoagulants (DOACs) as first-line therapy for the treatment of DVT over vitamin K antagonists (VKAs) due to their superior efficacy and safety profile 1, 2
For patients with acute DVT, anticoagulation should be initiated immediately upon diagnosis, and home treatment is recommended over hospital treatment, provided the patient has adequate home circumstances, support systems, and ability to access outpatient care 1, 2, 3
Early ambulation is suggested over initial bed rest for patients with acute DVT 1
For patients with low-risk pulmonary embolism (PE), outpatient treatment is suggested over hospitalization, provided appropriate outpatient care is accessible 1, 3

The American College of Chest Physicians recommends initial treatment with parenteral anticoagulation (low molecular weight heparin (LMWH), fondaparinux, intravenous unfractionated heparin (IV UFH), or subcutaneous unfractionated heparin (SC UFH)) for patients treated with vitamin K antagonist (VKA) therapy 1
LMWH or fondaparinux is suggested over IV or SC UFH due to superior efficacy and safety profile 1, 4
Early initiation of VKA (same day as parenteral therapy starts) is recommended with continuation of parenteral anticoagulation for a minimum of 5 days and until international normalized ratio (INR) is ≥2.0 for at least 24 hours 4

For DVT provoked by surgery or other transient risk factors, 3 months of anticoagulation is recommended 1, 2, 5
For unprovoked DVT, a minimum of 3 months of anticoagulation is recommended, with evaluation for extended therapy after this period 2, 5
For unprovoked proximal DVT with low or moderate bleeding risk, extended anticoagulation therapy is suggested 2, 5
For DVT associated with active cancer, extended anticoagulation therapy (no scheduled stop date) is recommended 1, 2

Inferior vena cava (IVC) filters are not recommended for patients with DVT who can be treated with anticoagulants 2, 4, 5
IVC filters are recommended for patients with acute proximal DVT who have contraindications to anticoagulation 4
Thrombolytic therapy is generally not recommended for most DVT patients but may be considered in select cases of extensive proximal DVT with limb-threatening conditions 4
For patients with upper extremity DVT involving the axillary or more proximal veins, anticoagulant therapy alone is suggested over thrombolysis 1

For patients with recurrent venous thromboembolism (VTE) on non-LMWH anticoagulants, switching to LMWH is suggested 2